Medtronic's Altaviva is a small device placed under the skin near the ankle and sends electrical pulses to the tibial nerve for tibial neuromodulation, a proven therapy for improving bladder control.
Clinical trial shows that after 12 months of therapy, 80% of patients reported improvement in their bladder symptoms, and 61% of patients reported at least 50% reduction in urgency urinary incontinence episodes.
The implant has a long-lasting battery expected to deliver 15 years of therapy. No sedation is required for implantation. Patients can walk out the same day with therapy activated.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.